Total submissions: 3
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000878465 | SCV001021377 | likely benign | Brachyolmia-amelogenesis imperfecta syndrome | 2025-02-03 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV002382019 | SCV002694668 | likely benign | Inborn genetic diseases | 2022-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Ce |
RCV003411873 | SCV004136923 | likely benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | LTBP3: BP4, BP7 |